Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™

By: Business Wire

Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 “Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™” be killed.

The release was issued in error by Aditxt, Inc..

A replacement release will not be issued at this time.

Contacts

Aditxt, Inc.

Corporate Communications

Jeff Ramson, PCG Advisory, Inc.

T: 646-863-6893

contactus@aditxt.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  242.05
+1.12 (0.46%)
AAPL  261.58
-0.78 (-0.30%)
AMD  210.04
-4.31 (-2.01%)
BAC  55.67
-1.58 (-2.75%)
GOOG  322.46
+7.91 (2.51%)
META  649.40
-11.22 (-1.70%)
MSFT  484.61
+6.10 (1.27%)
NVDA  188.94
+1.69 (0.91%)
ORCL  193.73
-0.02 (-0.01%)
TSLA  436.56
+3.60 (0.83%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback